Win 24540 Trilostane Inhibitor Cas 13647-35-3 For Cushing'S Syndrome
Win 24540 Trilostane Inhibitor Cas 13647-35-3 for Cushing's syndrome
| Product name:Trilostane Win 24540 | Purity:99% min |
| CAS NO:13647-35-3 | Solubility:DMSO: ≥17mg/mL |
| Molecular Formula:C20H27NO3 | Package:Package according to customer requirements |
| Molecular Weight:329.433 | Storage:Store at -20℃ |
Trilostane is an inhibitor of 3β-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome. It was withdrawn from the United States market in April 1994. However, it was recently approved in 2008 for the treatment of Cushing's disease (hyperandrenocorticism) in dogs. It is also the first drug approved to treat both pituitary- and adrenal-dependent Cushing's in dogs. This prescription drug works by stopping the production of cortisol in the adrenal glands.
Related Prodcuts:
Doramectin; Spinosad; Moxidectin; Milbemycin oxime; Imidacloprid; Fumagillin; Trilostane; Pimobendan; Maropitant Citrate; Fluralaner; Afoxolaner; Tiamulin famarate; Selamectin
- [1] Barker S, et al. J Steroid Biochem Mol Biol,?006, 100(4-5), 141-151.
- [2] Galac S, et al. Vet J,?010, 183(1), 75-80.
- [3] Gomez-Sanchez EP, et al. Am J Physiol Regul Integr Comp Physiol,?005, 288(2), R389-393.
Get in Touch
Have questions about our products or want to discuss a custom order? Our team is ready to help you.